STOCK TITAN

Limitless X (LIMX) sets $9M stock deal for 60% of Ding Easy AI

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Limitless X Holdings Inc. entered into a binding letter of intent for its subsidiary Bodycor, Inc. to acquire 60% of Ding Easy AI, LLC based on a $15,000,000 valuation. Ding’s owners will receive Company common stock valued at $9,000,000, issued as restricted shares.

Bodycor also plans to provide up to $1,750,000 in growth capital to Ding, with $750,000 funded in three tranches and the remaining $1,000,000 tied to performance milestones. After Ding reaches a $40,000,000 valuation, Bodycor may buy the remaining 40% for Company stock valued at $16,000,000. The deal is a related-party transaction reviewed and approved by the Audit Committee and includes a 120-day exclusivity period.

Positive

  • None.

Negative

  • None.

Insights

Limitless X signs related-party LOI for staged Ding Easy AI acquisition using stock and conditional growth capital.

Limitless X Holdings, through Bodycor, agreed to acquire 60% of Ding Easy AI at a $15,000,000 valuation, paying Ding’s owners in restricted common stock valued at $9,000,000. This structures the transaction as an equity deal rather than immediate cash outlay.

The LOI adds up to $1,750,000 of growth capital, with the first $750,000 in three $250,000 tranches and another $1,000,000 contingent on revenue and user-metric milestones. Timing and funding of this capital are explicitly non-binding, so actual cash deployment will depend on later decisions and performance.

Ding is controlled by Daniel Sanders, who also leads a Company subsidiary, making this a related-party transaction under Item 404(a). The Audit Committee reviewed and approved the terms, and the structure includes a 120-day exclusivity period plus an option for Bodycor to acquire the remaining 40% for Company stock valued at $16,000,000 once Ding reaches a $40,000,000 valuation. Overall impact on shareholders will hinge on future valuation, performance milestones, and any dilution from stock issuance.

false 0001803977 0001803977 2026-01-26 2026-01-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

January 26, 2026

Date of Report (Date of earliest event reported)

 

LIMITLESS X HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

Delaware   000-56453   81-1034163

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

9777 Wilshire Blvd., #400    
Beverly Hills, CA   90212
(Address of principal executive offices)   (Zip Code)

 

(855) 413-7030

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N./A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01 Entry into a Material Agreement.

 

Binding Letter of Intent

 

On January 26, 2026, Bodycor, Inc., a Nevada corporation (“Bodycor”), and Limitless X Holdings Inc., a Delaware corporation (the “Company”, which is the issuer of the Common Stock described herein), entered into a Binding Letter of Intent (the “LOI”) with Ding Easy AI, LLC, a Delaware limited liability company (“Ding”), and the equityholders of Ding (“Ding Owners”). Ding is a web and mobile platform that leverages its partnership with Maplebear Inc. d/b/a Instacart (NASDAQ: CART) to assist users in achieving health goals through the use of artificial intelligence to plan meals and generate grocery lists based on individualized dietary needs and budget requirements. Ding is wholly owned and controlled by Daniel Sanders, who also serves as the President of Limitless X, Inc., the Company’s wholly-owned subsidiary which sells nutritional supplements. As a result, the LOI constitutes a related-party transaction under Item 404(a) of Regulation S-K. The transaction terms and the President’s interest were reviewed and approved by the Audit Committee.

 

Pursuant to the LOI, Bodycor will acquire from the Ding Owners sixty percent (60%) of the equity interests of Ding on a fully diluted basis, assumed for valuation purposes to include an employee equity pool of fifteen percent (15%) and a pre-money valuation of fifteen million dollars ($15,000,000) (the “Valuation”). In exchange, the Ding Owners will receive shares of common stock of the Company (“Common Stock”) having an aggregate value of nine million dollars ($9,000,000) based on the volume-weighted average price per share of the Common Stock. The Comon Stock will be issued as restricted securities pursuant to Rule 144 of the Securities Act of 1933, as amended (the “Act”). Additionally, Bodycor will provide Ding with one million seven hundred and fifty thousand dollars ($1,750,000) of growth capital (“Growth Capital”), subject to Bodycor’s satisfactory completion of due diligence and the issuance of a fairness opinion with respect to the Valuation.

 

The first seven hundred and fifty thousand dollars ($750,000) of Growth Capital will be funded in three (3) tranches of two hundred and fifty thousand dollars ($250,000), each tied to an agreed use-of-proceeds schedule, budget categories, spend thresholds, and reporting covenants. Bodycor’s disbursement of the remaining one million dollars ($1,000,000) of Growth Capital will be contingent upon the achievement of certain objective and auditable milestones including revenue targets and user metrics. The timing and funding of the Growth Capital per the LOI is not binding on the parties.

 

Following Ding achieving a valuation of forty million dollars ($40,000,000), as determined pursuant to the LOI, Bodycor will have the right, but not the obligation, to acquire from the Ding Owners the remaining forty percent (40%) of the equity interests of Ding in a subsequent transaction (the “Second Sale”) in exchange for Common Stock having an aggregate value of sixteen million dollars ($16,000,000) based on the volume-weighted average price per share of the Common Stock immediately preceding the Second Sale. The LOI provides for an exclusivity period of one hundred and twenty (120) days.

 

The Company will provide audited financial statements of Ding within 60 days after the acquisition is completed.

 

The foregoing description of the LOI does not purport to be complete and is qualified in its entirety by reference to the full text of such document, a copy of which is filed as an exhibit to this Current Report on Form 8-K.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

To the extent applicable, the information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)   Exhibits
     
10.1   Binding Letter of Intent by and among Bodycor Inc., Limitless X Holdings Inc., and Ding Easy AI, LLC, dated January 26, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LIMITLESS X HOLDINGS INC.
     
Date: February 9, 2026 By: /s/ Jaspreet Mathur
  Name: Jaspreet Mathur
  Title: Chief Executive Officer

 

 

FAQ

What transaction did Limitless X Holdings (LIMX) announce with Ding Easy AI?

Limitless X, via its subsidiary Bodycor, signed a binding letter of intent to acquire 60% of Ding Easy AI at a $15,000,000 valuation. Ding’s owners will receive $9,000,000 of Limitless X common stock, issued as restricted shares, instead of cash consideration.

How much will Ding Easy AI’s owners receive in Limitless X stock?

Ding Easy AI’s owners are set to receive Limitless X common stock valued at $9,000,000. The value is based on the volume-weighted average price of the common stock, and the shares will be issued as restricted securities under the letter of intent.

What growth capital is Bodycor committing to Ding Easy AI under the LOI?

Bodycor plans to provide up to $1,750,000 in growth capital to Ding Easy AI. The first $750,000 will be funded in three $250,000 tranches, while the remaining $1,000,000 depends on achieving objective revenue and user-metric milestones described in the letter of intent.

Why is the Ding Easy AI deal a related-party transaction for Limitless X (LIMX)?

The deal is a related-party transaction because Ding Easy AI is wholly owned and controlled by Daniel Sanders, who also serves as President of Limitless X’s wholly-owned subsidiary. The Audit Committee reviewed and approved both the transaction terms and this management relationship.

Does Bodycor have an option to buy the remaining Ding Easy AI equity?

Yes. After Ding Easy AI reaches a $40,000,000 valuation as defined in the LOI, Bodycor may acquire the remaining 40% equity. That potential second sale would be paid in Limitless X common stock valued at $16,000,000, based on the stock’s volume-weighted average price before closing.

What exclusivity and reporting terms are included in the Ding Easy AI LOI?

The letter of intent includes a 120-day exclusivity period during which parties focus on this transaction. Limitless X will provide audited financial statements of Ding within 60 days after completing the acquisition, adding post-closing financial transparency around the acquired business.

Filing Exhibits & Attachments

4 documents
Limitless X

OTC:LIMX

LIMX Rankings

LIMX Latest News

LIMX Latest SEC Filings

LIMX Stock Data

29.58M
6.16M
63.62%
Packaged Foods
Consumer Defensive
Link
United States
Beverly Hills